I 
118TH CONGRESS 
2D SESSION 
H. R. 8299 
To require the Secretary of Health and Human Services, in consultation 
with the Secretary of Commerce, the Council for Technology and Innova-
tion of the Centers for Medicare & Medicaid Services, and the Commis-
sioner of Food and Drugs, to carry out a program to facilitate and 
coordinate efforts between the United States and Israel to expand and 
enhance collaboration on the development and delivery of health care 
products and services. 
IN THE HOUSE OF REPRESENTATIVES 
MAY 8, 2024 
Mr. BUCHANAN (for himself, Mr. SOTO, and Mrs. MILLER-MEEKS) introduced 
the following bill; which was referred to the Committee on Energy and 
Commerce 
A BILL 
To require the Secretary of Health and Human Services, 
in consultation with the Secretary of Commerce, the 
Council for Technology and Innovation of the Centers 
for Medicare & Medicaid Services, and the Commissioner 
of Food and Drugs, to carry out a program to facilitate 
and coordinate efforts between the United States and 
Israel to expand and enhance collaboration on the devel-
opment and delivery of health care products and services. 
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
VerDate Sep 11 2014 
03:55 Jun 07, 2024
Jkt 049200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H8299.IH
H8299
kjohnson on DSK7ZCZBW3PROD with $$_JOB
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Maximizing Israel-U.S. 
Research Advancement and Collaborative Leadership in 
Emerging Medical Technology Act of 2024’’ or the ‘‘MIR-
ACLE Medical Technology Act of 2024’’. 
SEC. 2. PROGRAM FOR FACILITATION AND COORDINATION 
OF UNITED STATES-ISRAEL EFFORTS ON THE 
DEVELOPMENT AND DELIVERY OF HEALTH 
CARE PRODUCTS AND SERVICES. 
(a) IN GENERAL.—Subject to the availability of ap-
propriations, the Secretary of Health and Human Serv-
ices, in consultation with the Secretary of Commerce, the 
Council for Technology and Innovation of the Centers for 
Medicare & Medicaid Services, and the Commissioner of 
Food and Drugs, shall carry out a program to facilitate 
and coordinate efforts between the United States and 
Israel to expand and enhance collaboration on— 
(1) the development of health care products and 
services; and 
(2) the delivery of such products and services to 
those in need. 
(b) PROGRAM COMPONENTS.—The program under 
subsection (a) shall include facilitation and coordination 
of efforts including each of the following: 
(1) RESEARCH AND DEVELOPMENT.— 
VerDate Sep 11 2014 
03:55 Jun 07, 2024
Jkt 049200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H8299.IH
H8299
kjohnson on DSK7ZCZBW3PROD with $$_JOB
(A) Joint research projects between United 
States and Israeli institutions and companies. 
(B) Promoting collaboration in areas such 
as medical device technology, pharmaceuticals 
including biological products, genomics, and in-
novative digital health care solutions and health 
care systems management, including a special 
focus on early-stage clinical trials. 
(C) With respect to biological products, 
supporting— 
(i) innovation; 
(ii) process optimization; and 
(iii) the development of advanced 
manufacturing techniques that can en-
hance productivity, reduce costs, and im-
prove product quality. 
(D) Work toward developing a framework 
for sharing health data for research purposes 
with the Ministry of Health of Israel. 
(2) INNOVATION AND START-UP ECOSYSTEM.— 
(A) Fostering collaboration between United 
States and Israeli start-up and other companies 
in the health care sector. 
(B) Facilitating innovative technology ac-
ceptance by the marketplace. 
VerDate Sep 11 2014 
03:55 Jun 07, 2024
Jkt 049200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H8299.IH
H8299
kjohnson on DSK7ZCZBW3PROD with $$_JOB